TGF-β Type I Receptor Kinase Inhibitor EW-7197 Suppresses Cholestatic Liver Fibrosis by Inhibiting HIF1α-Induced Epithelial Mesenchymal Transition

Min‐Jin Kim, Sang-A Park, Chun Hwa Kim, So-Yeon Park, Jung‐Shin Kim, Dae‐Kee Kim, Jeong‐Seok Nam, Yhun Yhong Sheen

Cellular Physiology and Biochemistry · 2016 · 51 citations · 37 references

DOIFull text

Open access

Abstract

This study suggests that EW-7197 exhibits potential as a treatment for liver fibrosis because it inhibits HIF1α-induced TGF-β signaling.

References

37